Minerva Neurosciences, Inc. (NERV)


Stock Price Forecast

April 19, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Minerva Neurosciences, Inc. chart...

About the Company

We do not have any company description for Minerva Neurosciences, Inc. at the moment.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

8

Exchange

Nasdaq

$41M

Total Revenue

8

Employees

$17M

Market Capitalization

-0.54

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $NERV News

Minerva Neurosciences, Inc. (NERV)

1d ago, source: Yahoo Finance

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected ...

Minerva Neurosciences Inc

3mon ago, source: CNN

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous ...

Minerva Neurosciences Inc NERV

5d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Minerva Neurosciences Inc NERV

6d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Minerva Neurosciences, Inc. (NERV)

1y ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Minerva Neurosciences, Inc Common Stock (NERV)

4y ago, source: Nasdaq

Nasdaq provides company’s SEC filings, which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia. The SEC ...

Minerva Neurosciences Inc.

11mon ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Minerva Neurosciences Inc

1mon ago, source: U.S. News & World Report

Analysts say these cheap stocks have plenty of upside.

Minerva Neurosciences, Inc. (NERV)

1d ago, source: Yahoo Finance

*Close price adjusted for splits.**Close price adjusted for splits and dividend and/or capital gain distributions. Loading more data ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...